A 53-year-old male was transported to the Emergency Department of Korea University Anam Hospital in Seoul. He was involved in a motor-vehicle collision at 40 km/h. The helmet was damaged, revealing two lacerations on the forehead. He complained of pain in both thighs and had multiple bruises and abrasions on both lower extremities. He recalled losing consciousness for several minutes after the collision. The patient arrived with a fixed cervical spine, and the wound was covered.
The patient had underlying medical conditions such as hypertension, diabetes mellitus, chronic kidney disease, Hepatitis C, and angina. He underwent percutaneous coronary intervention stent insertion in 2016, pan-retinal laser coagulation for diabetic retinopathy in both eyes in 2021, and arteriovenous fistula construction for hemodialysis in 2021.
Upon arrival, his vital signs were stable, his mental status was alert, and the focused abdominal sonography in trauma was negative. No significant hemorrhage or fracture was visible on simple radiography or computed tomography of the abdominopelvic region, chest, or brain. The lacerations on the left tibia and right forehead were sutured in the Emergency Room. The Plastic Surgery department planned delayed primary closure with a local flap for the right forehead laceration as well as incision and drainage of the eyebrow hematoma. On the third day of admission, he began sweating unpleasantly. He had to change clothes several times daily because of excessive sweating (Figure 1). Moreover, he complained of chills, headache, and increased thirst. Symptoms were relieved only after hemodialysis but recurred the next day (Figure 2). Therefore, several tests were conducted to evaluate the potential causes (Table 2). As noted in (Table 1), hyperhidrosis can be triggered by either chronic or acute causes. In this case, the patient’s symptoms began after the accident; therefore, we mainly focused on acute causes. However, all radiological, serological, and psychological tests were negative. Brain and spine imaging revealed no evidence of bleeding or trauma. Laboratory test results and imaging of endocrinological abnormalities were normal. Bacterial cultures and laboratory tests for signs of infection yielded negative results. Furthermore, psychiatric survey results were normal, and autonomic function tests were not indicative of his symptoms. Transthoracic echocardiography and electrocardiography were performed to check for cholinergic crisis; however, they were unrelated to cholinergic toxicity, and vital signs were normal (Table 2).
Table 2. Assessment of hyperhidrosis
|
Differential diagnosis
|
Modality
|
Result
|
Central structural lesion
|
Brain MRI, CT
|
No microbleeding or traumatic damage
|
Endocrinological abnormalities
(eg. Pheochromocytoma, hyperthyroidism, hyperaldosteronism)
|
APCT
|
no adrenal lesion
|
Lab
|
metanephrine, norepinephrine, dopamine normal or mildly elevated.
ACTH mildly elevated, cortisol, aldosterone, TSH normal
|
Bacteremia
|
Culture
|
Forehead laceration culture: ADM 5 Pseudomonas monteilii
Blood culture: ADM 6 Staphylococcus epidermidis - negative after ADM 12
|
Lab
|
Procalcitonin 0.13 (ADM 1) 7.07 (ADM 13) 0.181 (ADM 36) ng/mL
CRP 2.37 (ADM 1) 8.03 (ADM 4) 2.20 (ADM 9) 25.57 (ADM 11) 3.23 (ADM 16) 1.93 (ADM 18) mg/L
|
TB
|
PCR, culture
|
negative
|
Autonomic nervous system abnormality
|
K-COMPASS (composite autonomic symptom score)
|
31 (no other symptom than cold sweating)
|
Autonomic function test (QSART)
|
delayed orthostatic hypotension, parasympathetic dysfunction, increased sweat secretion
|
Cord injury
|
Spine MRI, CT
|
inflammatory spondyloarthropathy, disc bulgings, neural foramen stenosis
No remarkable cords signal changes nor enhancement
No spinal fracture
|
Hypoglycemia
|
Blood sugar
|
WNL
|
Psychiatric cause
|
HADS (Hospital anxiety and depression scale)
BDI (Beck depression inventory test)
|
normal
|
Cardiovascular
|
Transthoracic Echocardiography
|
Left ventricular (LV) eccentric hypertrophy, LV and atrial enlargement, prominent trabeculation at the LV apex, no regional wall motion abnormality of LV, low normal LV ejection fraction (54%), small amount of pericardial effusion (right ventricle side), Chiari network in the right atrium, mild tricuspid regurgitation, moderate pulmonary hypertension, thickened aortic valve and mitral valve
|
Electrocardiogram
|
Sinus rhythm, incomplete left bundle branch block, left ventricular hypertrophy, anterior infarct, possibly acute
|
ACTH - Adrenocorticotropic Hormone; ADM – Admission; APCT - Abdominopelvic Computed Tomography; BDI - Beck Depression Inventory; CRP - C-reactive Protein; CT - Computed Tomography; HADS - Hospital Anxiety and Depression Scale; K-COMPASS - Composite Autonomic Symptom Score; LV - Left Ventricle; MRI - Magnetic Resonance Imaging; PCR - Polymerase Chain Reaction; QSART - Quantitative Sudomotor Axon Reflex Test; TSH - Thyroid-stimulating Hormone; WNL - Within Normal Limits
Table 3. Symptomatic treatment and results
|
Treatment
|
Expectation
|
Result
|
Amitriptyline (TCA)
|
Anticholinergic effect
|
no effect
|
Sympathetic ganglion block (mepivacaine) at ADM 27, 28, 29, 33, 35
|
Suppress overactive sympathetic tone
|
no effect
|
TCA - Tricyclic Antidepressant
Ineluctably, we initiated symptomatic management without identifying the cause (Table 3). Initially, the patient showed an improvement in symptoms following sympathetic ganglion blockade; however, the symptoms recurred the following day. Several more blockades were administered, yet their effectiveness varied each time. Initially, the treatment seemed to have only a temporary effect; later observations revealed that symptom resolution occurred exclusively on the hemodialysis days. He also tried amitriptyline, anticipating its anticholinergic effects, following consultation with the Neurology Department; however, it proved ineffective.
Next, we assessed his weight change to determine if symptom improvement correlated with achieving an adequate dry-weight. His recorded height was 172 cm, and the Nephrology Department recommended a dry weight of 68.3 kg, revised from previous estimates of 69.5 and 68.5 kg due to early-detected cardiomegaly on chest radiography. Upon admission, his weight was 68.7 kg, which rose to 72.5 kg with ADM 14. Subsequently, following ADM 25, his weight stabilized between 66 and 69 kg, with ultrafiltration generally maintained at 0 ml, except on some occasions when it reached up to 800 mL (Figure 3). However, despite his dry body volume, he continued to experience excessive sweating. Moreover, the effectiveness of hemodialysis in alleviating his symptoms was evident. To evaluate the effectiveness of hemodialysis, we reviewed laboratory data prior to each session. His results consistently indicated significantly elevated blood urea nitrogen, creatinine, potassium, and phosphorus levels typical of chronic kidney disease, with these elevations largely mitigated following hemodialysis. The osmolality was calculated using the formula:
*** Osmolality = (2 × Na) + (blood urea nitrogen / 2.8) + (glucose / 18).
They were persistently high, and although not significantly, they were relieved after hemodialysis.
Prior to admission, the patient’s daily medications included: torsemide: 2.5 mg, losartan 100 mg, amlodipine 5 mg, carvedilol 6.25 mg, teneligliptin 20 mg, rosuvastatin 10 mg, nifedipine 30 mg, vitamin supplements QD, polystyrene sulfonate calcium 5 g BID, and sevelamer carbonate 800 mg TID, primarily for cardiologic and nephrologic conditions. For enhanced bowel and urinary function, the followings were administered: magnesium hydroxide 500 mg BID, motilitone (Coridalis tuber, Pharbitis seed) 30 mg, bethanechol 25 mg TID, and tamsulosin 0.2 mg HS. These additional medications were discontinued upon discharge.
Fortunately, the patient’s excessive sweating ceased three days after discharge. He no longer had to shower or change clothes several times. No further laboratory or imaging tests were performed. The patient remained dry for 10 months.